We are live on ! Find out more
REPL icon

Replimune Group
REPL

135 hedge funds and large institutions have $1.29B invested in Replimune Group in 2022 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 24 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

15,989% more call options, than puts

Call options by funds: $4.34M | Put options by funds: $27K

725% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 4

158% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 24

133% more funds holding in top 10

Funds holding in top 10: 3 → 7 (+4)

83% more capital invested

Capital invested by funds: $704M → $1.29B (+$587M)

27% more funds holding

Funds holding: 106 → 135 (+29)

14.22% more ownership

Funds ownership: 82.66% → 96.88% (+14%)

Holders
135
Holders Change
+29
Holders Change %
+27.36%
% of All Funds
2.17%
Holding in Top 10
7
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+133.33%
% of All Funds
0.11%
New
33
Increased
62
Reduced
24
Closed
4
Calls
$4.34M
Puts
$27K
Net Calls
+$4.32M
Net Calls Change
+$1.57M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$24.7M
2
CCM
Camber Capital Management
Massachusetts
+$20.8M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$18.6M
4
BBA
Baker Bros. Advisors
New York
+$14.2M
5
BI
BVF Inc
California
+$12.4M

Top Sellers

Rank Fund Capital Flow
1
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
-$21M
2
OFM
Omega Fund Management
Massachusetts
-$19.2M
3
GPP
Great Point Partners
Connecticut
-$6.74M
4
AG
Artal Group
Luxembourg
-$4.16M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.87M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$11M +$439K +21,143 +5%
Wellington Management Group
27
Wellington Management Group
Massachusetts
$7.73M +$5.36M +257,842 +974%
Millennium Management
28
Millennium Management
New York
$7.49M +$2.85M +137,383 +99%
Ensign Peak Advisors
29
Ensign Peak Advisors
Utah
$7.34M +$4.49M +215,840 +398%
Charles Schwab
30
Charles Schwab
California
$7.06M +$152K +7,337 +3%
IHAM
31
Integral Health Asset Management
New York
$5.98M +$416K +20,000 +10%
Ameriprise
32
Ameriprise
Minnesota
$5.84M -$41.4K -1,990 -0.9%
RCAP
33
Resolute Capital Asset Partners
Colorado
$5.71M +$4.36M +210,000 New
N
34
Nuveen
North Carolina
$5.38M +$1.28M +61,447 +45%
SAM
35
Sectoral Asset Management
Quebec, Canada
$5.34M +$4.08M +196,500 New
Renaissance Technologies
36
Renaissance Technologies
New York
$5.21M +$1.07M +51,353 +37%
NFGH
37
Nan Fung Group Holdings
Hong Kong
$5.15M +$709K +34,140 +22%
Bank of New York Mellon
38
Bank of New York Mellon
New York
$4.56M +$437K +21,007 +14%
ACM
39
Altium Capital Management
New York
$4.35M +$3.32M +160,000 New
JP Morgan Chase
40
JP Morgan Chase
New York
$4.15M -$253K -12,179 -7%
Goldman Sachs
41
Goldman Sachs
New York
$4.09M -$723K -34,788 -19%
Norges Bank
42
Norges Bank
Norway
$3.85M +$1.05M +50,400 +55%
Deutsche Bank
43
Deutsche Bank
Germany
$3.85M +$104K +5,015 +4%
TD Asset Management
44
TD Asset Management
Ontario, Canada
$3.62M +$581K +27,962 +27%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$3.51M +$2.68M +128,969 New
Marshall Wace
46
Marshall Wace
United Kingdom
$3.44M +$2.63M +126,567 New
OCM
47
Osterweis Capital Management
California
$3.1M -$214K -10,285 -8%
Two Sigma Advisers
48
Two Sigma Advisers
New York
$3.04M -$224K -10,800 -9%
ECM
49
ExodusPoint Capital Management
New York
$2.93M +$1.95M +94,044 +693%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.82M +$504K +24,252 +31%
1
2
3 4 5

REPL Hedge Fund Activity: Q4 2022 in Review

135 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2022, worth a combined $1.29B — up 83% from $704M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new REPL positions and 4 closed out — a net gain of 29 holders — while 62 added to existing stakes and 24 trimmed.

The largest buyer was Redmile Group, adding an estimated $24.7M. The largest seller was Atlas Venture Life Science Advisors, cutting an estimated $21M.

  • 135 institutional investors held Replimune Group (REPL) as of Q4 2022, up from 106 in Q3 2022.
  • Funds reported $1.29B of Replimune Group stock for Q4 2022, up 83% quarter-over-quarter.
  • 33 funds opened new Replimune Group positions in Q4 2022 and 4 closed out, a net change of +29 holders.
  • The largest Replimune Group buyer in Q4 2022 was Redmile Group, an estimated $24.7M added.
  • The largest Replimune Group seller in Q4 2022 was Atlas Venture Life Science Advisors, an estimated $21M sold.

Based on aggregated 13F filings for Q4 2022.